期刊文献+

原位心脏移植术后早期肾功能损伤的防治 被引量:3

Prevention and therapy of early renal damage after orthotopic heart transplantation
原文传递
导出
摘要 目的分析原位心脏移植术后受者早期肾功能损伤情况,探讨其发生原因及防治措施。方法浙江省人民医院心胸外科于1997年6月至2011年12月期间对16例受者行原位心脏移植手术。供、受者ABO血型相合15例,不相合1例。淋巴细胞毒性试验阳性(〈10%)。受者术前肝肾功能均有一定程度损伤,需服用较大剂量利尿剂控制。6例受者采用环孢素(或他克莫司)+硫唑嘌呤(或吗替麦考酚酯)+糖皮质激素三联免疫抑制方案。10例受者在三联免疫抑制方案基础上加用单克隆抗体。结果 16例受者均顺利完成手术,术后均有不同程度的肾功能损伤。4例受者术后出现急性肾功能衰竭,其中1例血型不相合受者术后第7天移植心脏发生超急性排斥反应合并急性肾功能衰竭,血液透析后第10天死亡;1例受者移植术后第21天因急性肾功能衰竭合并肺部感染死亡。截至2013年3月31日,术后随访15~201个月(中位随访时间96个月),受者1,3,5年生存率分别为87.5%,81.3%,75.0%。结论心脏移植受者术前心功能状态、手术操作以及使用肾毒性药物、感染都会引起术后肾功能损伤,只要积极预防、及时诊断、有效处理,可避免或减轻肾功能损伤,提高心脏移植围术期成功率。 Objective To analysis the early renal damage in orthotopic heart transplantation recipients,and to explore its causes and prevention measures.Method From June 1997 to December2011,a total of 16 recipients underwent orthotopic heart transplantation surgery in Zhejiang Provincial People's Hospital.Results Sixteen transplant recipients have different degrees of renal impairment,including 4 patients( 25%) in acute renal failure after surgery,2 patients died.The median follow-up period was 96 months( 15—201).The 1-,3-,5-year survival rate was 87.5%,81.3%,75.0%,respectively.Conclusion Heart transplant patients preoperative heart function,operation and use of nephrotoxicity drugs can cause renal damage after the operation.As long as the stereo prevention timely and effective treatment,can improve survival after heart transplantation.
出处 《中华移植杂志(电子版)》 CAS 2013年第3期6-8,16,共4页 Chinese Journal of Transplantation(Electronic Edition)
关键词 原位心脏移植 肾功能损伤 预防 治疗 Orthotopic heart transplantation Renal damage Prevention Treatment
  • 相关文献

参考文献10

  • 1陈昊,王春生,赖颢,宋凯,洪涛,姜桢.原位心脏移植术后肾功能损害的防治[J].上海医学,2002,25(9):569-571. 被引量:3
  • 2张振,王武军,廖崇先,李增琪,邹小明,蔡开灿.心脏移植术后肾功能监测与治疗[J].广东医学,2001,22(10):920-921. 被引量:5
  • 3Adams HP Jr, Adams RJ, Brott T, et al. Guidelines for the earlymanagement of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke, 2003,4(4) : 1056-083.
  • 4陈子道.心脏移植术后肾功能衰竭//夏求明.现代心脏移植.北京:人民卫生出版社,1998:200-205.
  • 5李建强,宋云虎,黄洁.心脏移植术后早期急性肾功能衰竭的影响因素分析.中国循环杂志,2011,26(增刊):295.
  • 6Tsimaratos M, Viard L, Kreitmann B, et al. Kidney function in cy- closporine-treated paediatric pulmonary transplant recipients. Trans- plantation, 2000,69 (10) :2055-2059.
  • 7MacLeod AM, Thomson AW. FK-506. A new immunosuppressive drug. Medicina ( Firenze), 1990,10 (3) :329-332.
  • 8Tinawi M, Miller L, Bastani B. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a sin- gle center. Clin Transplant, 1997,11 (1) :1-8.
  • 9Aleksic I, Baryalei M, Busch T, et al. Improvement of impaired re- nal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine. Transplantation, 2000,69 ( 8 ) : 1586-1590.
  • 10廖东山,李增棋,廖崇先,陈道中,陈良万.低剂量环孢素A在心脏移植中的应用[J].福建医科大学学报,2008,42(6):536-538. 被引量:2

二级参考文献15

  • 1陈子道 夏求明.心脏移植术后肾功能衰竭.现代心脏移植,第1版[M].北京:人民卫生出版社,1998.200-205.
  • 2Cooper D K C, Miller L W, Patterson G A, etal. The transplantation and replacement of thoracic organs[M]. Lancaster: Kluwer Academic Publishers, 1996173-76,275-279.
  • 3Tinawi M, Miller L, Bastani B. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center[J]. Clin Transplant , 1997,11(1) : 1-8.
  • 4Rosenberg P B, Vriesendorp A E, Drazner M H, etal. Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation[J]. J Heart and Lung Transplant, 2005,24(9): 1327-1331.
  • 5Wang S S, Chou N K, Chi N H, et al. Heart transplantation under eyelosporine or tacrolimus combined with mycophenolate mofetil or everolimus [J]. Transplant Proc, 2008, 40 (8) : 2607-2608.
  • 6Lake J R, David K M, Steffen B J, et al. Addition of MMF to dual immunosuppression does not increase the risk of malignant short - term death after liver transplantation[J]. Am J Transplant, 2005,5 (12) :2961-2967.
  • 7Beniaminovitz A, Iteseu S, Lietz K, etal. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody [J]. N Engl J Med, 2000,342(9) : 613-619.
  • 8Mastrobuoni S, Ubilla M, Cordero A, et al. Two-dose daclizumab, taerolimus, myeophenolate mofetil, and steroid-free regimen in de novo cardiac transplant recipients: early experience[J]. Transplant Proc , 2007,39(7) :Z163-2166.
  • 9[1]Billingham ME,Cary NRB,Hammond ME,et al.A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection:Heart Rejection Study Group.J Heart Transplant, 1990, 9:587
  • 10[2]Hornberger J,Best J,Geppert J,et al.Risks and costs of end-stage renal disease after heart transplantation. Transplantation, 1998, 66(12): 1763

共引文献7

同被引文献15

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部